{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Spring Valley",
      "state": "NY",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72476",
      "recalling_firm": "Par Pharmaceutical Inc.",
      "address_1": "1 Ram Ridge Rd",
      "address_2": "N/A",
      "postal_code": "10977-6714",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S. Nationwide including Puerto Rico",
      "recall_number": "D-0233-2016",
      "product_description": "Meclizine Hydrochloride Tablets, USP, 12.5 mg Tablets, Packaged in a) 100 Ct Bottles (NDC: 49884-034-01) and b) 1000 Ct Bottles (NDC: 49884-034-10), Rx only. Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977.",
      "product_quantity": "a) 162,385 Bottles; b) 6949 Bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for impurities.",
      "recall_initiation_date": "20151026",
      "center_classification_date": "20151113",
      "termination_date": "20170420",
      "report_date": "20151125",
      "code_info": "a)  Lot #: 24820001, Expiry: NOV 2015; Lot #: 25783601, Expiry: OCT 2016; Lot #: 25783801, Expiry: OCT 2016;  Lot #: 26731201, Expiry: AUG 2017;  Lot #: 26762002, Expiry: FEB 2018. b) Lot #:  26683201, Expiry: AUG 2017; Lot#: 26762001, Expiry: FEB 2018."
    }
  ]
}